Literature DB >> 25693852

Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice.

Hisashi Sawada1, Yoshiro Naito1, Makiko Oboshi1, Toshihiro Iwasaku1, Yoshitaka Okuhara1, Daisuke Morisawa1, Akiyo Eguchi1, Shinichi Hirotani1, Tohru Masuyama1.   

Abstract

Excess iron is associated with the pathogenesis of several renal diseases. Aldosterone is reported to have deleterious effects on the kidney, but there have been no reports of the role of iron in aldosterone/salt-induced renal injury. Therefore, we investigated the effects of dietary iron restriction on the development of hypertension and renal injury in aldosterone/salt-induced hypertensive mice. Ten-week-old male C57BL/6J mice were uninephrectomized and infused with aldosterone for four weeks. These were divided into two groups: one fed a high-salt diet (Aldo) and the other fed a high-salt with iron-restricted diet (Aldo-IR). Vehicle-infused mice without a uninephrectomy were also divided into two groups: one fed a normal diet (control) and the other fed an iron-restricted diet (IR) for 4 weeks. As compared with control and IR mice, Aldo mice showed an increase in both systolic blood pressure and urinary albumin/creatinine ratio, but these increases were reduced in the Aldo-IR group. In addition, renal histology revealed that Aldo mice exhibited glomerulosclerosis and tubulointerstitial fibrosis, whereas these changes were attenuated in Aldo-IR mice. Expression of intracellular iron transport protein transferrin receptor 1 was increased in the renal tubules of Aldo mice compared with control mice. Dietary iron restriction attenuated the development of hypertension and renal injury in aldosterone/salt-induced hypertensive mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693852     DOI: 10.1038/hr.2015.13

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  25 in total

1.  Enhanced expression of bone morphogenetic protein system in aldosterone-treated mouse kidneys.

Authors:  Jiro Suzuki; Fumio Otsuka; Yoshinori Matsumoto; Kenichi Inagaki; Tomoko Miyoshi; Masaya Takeda; Naoko Tsukamoto; Eri Nakamura; Kanako Ogura; Hirofumi Makino
Journal:  Hypertens Res       Date:  2011-11-10       Impact factor: 3.872

Review 2.  Labile iron pool: the main determinant of cellular response to oxidative stress.

Authors:  Marcin Kruszewski
Journal:  Mutat Res       Date:  2003-10-29       Impact factor: 2.433

3.  Albuminuria in untreated patients with primary aldosteronism or essential hypertension.

Authors:  J M Halimi; A Mimran
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

4.  Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.

Authors:  Jun Irita; Takafumi Okura; Masanori Jotoku; Tomoaki Nagao; Daijiro Enomoto; Mie Kurata; Veena Rasika Desilva; Ken-Ichi Miyoshi; Yutaka Matsui; Toshimitsu Uede; David T Denhardt; Susan R Rittiling; Jitsuo Higaki
Journal:  Am J Physiol Renal Physiol       Date:  2011-07-06

5.  Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts.

Authors:  Yukiko Nagai; Kayoko Miyata; Guang-Ping Sun; Matlubur Rahman; Shoji Kimura; Akira Miyatake; Hideyasu Kiyomoto; Masakazu Kohno; Youichi Abe; Masanori Yoshizumi; Akira Nishiyama
Journal:  Hypertension       Date:  2005-08-08       Impact factor: 10.190

6.  Plasma aldosterone is independently associated with the metabolic syndrome.

Authors:  Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

7.  In vivo characterization of renal iron transport in the anaesthetized rat.

Authors:  M Wareing; C J Ferguson; R Green; D Riccardi; C P Smith
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

8.  Iron accumulation in human chronic renal disease.

Authors:  B J Nankivell; R A Boadle; D C Harris
Journal:  Am J Kidney Dis       Date:  1992-12       Impact factor: 8.860

9.  Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Shinichi Hirotani; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Mitsumasa Ohyanagi; Takeshi Tsujino; Tohru Masuyama
Journal:  J Hypertens       Date:  2013-06       Impact factor: 4.844

10.  Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.

Authors:  J Ma; A Weisberg; J P Griffin; D E Vaughan; A B Fogo; N J Brown
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

View more
  9 in total

1.  Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

Authors:  Makiko Oboshi; Yoshiro Naito; Hisashi Sawada; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Shinichi Hirotani; Toshiaki Mano; Takeshi Tsujino; Tohru Masuyama
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

2.  Possible therapeutic impact of the iron chelation on renal fibrosis.

Authors:  Kouichi Tamura; Kazushi Uneda; Kengo Azushima; Hiromichi Wakui; Kotaro Haruhara
Journal:  Hypertens Res       Date:  2015-04-16       Impact factor: 3.872

3.  Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Hypertens Res       Date:  2016-09-08       Impact factor: 3.872

4.  The Central Role of Neutrophil Gelatinase-Associated Lipocalin in Cardiovascular Fibrosis.

Authors:  Jane A Leopold
Journal:  Hypertension       Date:  2015-05-18       Impact factor: 10.190

5.  Increased Dietary Salt Intake Does Not Influence Influenza A Virus-Induced Disease Severity in Mice.

Authors:  Samuel Amoah; Weiping Cao; Priya Ranjan; Patricia Greer; Wun-Ju Shieh; Sherif R Zaki; Jacqueline M Katz; Suryaprakash Sambhara; Shivaprakash Gangappa
Journal:  Viral Immunol       Date:  2015-08-18       Impact factor: 2.257

6.  Influence of dietary iron intake restriction on the development of hypertension in weanling prehypertensive rats.

Authors:  Keisuke Okuno; Yoshiro Naito; Seiki Yasumura; Hisashi Sawada; Makiko Oboshi; Koichi Nishimura; Masanori Asakura; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2018-02-07       Impact factor: 2.037

Review 7.  Iron in Cardiovascular Disease: Challenges and Potentials.

Authors:  Shizhen Li; Xiangyu Zhang
Journal:  Front Cardiovasc Med       Date:  2021-11-30

Review 8.  Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases.

Authors:  Fang Yan; Kaifeng Li; Wenjuan Xing; Mingqing Dong; Mingliang Yi; Haifeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-09-07       Impact factor: 7.310

9.  Aldosterone induces NRK-52E cell apoptosis in acute kidney injury via rno-miR-203 hypermethylation and Kim-1 upregulation.

Authors:  Xiangcheng Xiao; Rong Tang; Xiao Zhou; Ling Peng; Pingping Yu
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.